Helen F Graham Cancer Center — Newark, Delaware

Helen F Graham Cancer Center is a clinical research site located in Newark, Delaware, United States 19713.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Helen F Graham Cancer Center has participated in 302 clinical trials with 200 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphedema.

Sponsors: National Cancer Institute (NCI), Gynecologic Oncology Group, ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Helen F Graham Cancer Center?

Helen F Graham Cancer Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Helen F Graham Cancer Center conducted?

Helen F Graham Cancer Center has 302 clinical trials on record, with 200 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphedema.

Is Helen F Graham Cancer Center accredited by Crixeo Health?

Helen F Graham Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Helen F Graham Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.